Capitalization 12.4B 1.7B 132B P/E ratio 2024 *
60x
P/E ratio 2025 * 39.8x
Enterprise value 11.47B 1.58B 122B EV / Sales 2024 *
7.83x
EV / Sales 2025 * 5.74x
Free-Float
67.87%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
Inner Mongolia Furui Medical Science Expects Up to 105% Increase in H1 Profit MT
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Furui Medical Science's 2023 Attributable Profit Rises 5% on Higher Operating Income MT
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1 CI
Theraclion Medical Equipment Co., Ltd. announced that it expects to receive funding from Inner Mongolia Furui Medical Science Co., Ltd. CI
Inner Mongolia Furui Medical Science Co., Ltd.(XSEC:300049) added to S&P Global BMI Index CI
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Inner Mongolia Furui Medical Science's Profit to Jump Up to 46% in H1 MT
Inner Mongolia Furui Medical Science Co., Ltd. Announces Board Appointments CI
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Inner Mongolia Furui Medical Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day-4.29%
1 week-5.76%
Current month-7.43%
1 month-13.09%
3 months-7.54%
6 months+29.55%
Current year+6.91%
More quotes
1 week
46.58
Extreme 46.58
49.90
1 month
46.58
Extreme 46.58
54.48
Current year
28.73
Extreme 28.73
57.50
1 year
20.60
Extreme 20.6
57.50
3 years
9.94
Extreme 9.94
57.50
5 years
6.67
Extreme 6.67
57.50
10 years
6.67
Extreme 6.67
74.94
More quotes
Insider TitleAgeSince
Chief Executive Officer 54 31/10/98
Director of Finance/CFO 53 31/12/07
Director/Board Member 60 19/05/20
Insider TitleAgeSince
Chief Executive Officer 54 31/10/98
Director/Board Member 63 19/05/20
Chairman 56 31/08/03
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-4.29%-5.76%+118.78%+149.06% 1.7B
+0.27%-11.08%-39.63%-56.21% 15.12B
+4.41%+8.17%-57.55%-75.41% 2.47B
-3.32%+2.74%+28.31% - 1.43B
+0.80%-1.91%+42.47%-18.86% 1.39B
-3.58%+8.12%-22.83% - 862M
-1.62%-0.97%-8.42%-56.55% 837M
-2.07%-0.08%-44.60%-78.49% 705M
+1.39%-3.25%-37.20%-45.41% 595M
+1.65%-11.72%+4.56%-42.32% 536M
Average -0.96%-0.97%-1.61%-28.02% 2.57B
Weighted average by Cap. -1.49%-4.75%-20.15%-41.13%
See all sector performances

Financials

Ratios2024 *2025 *
Net sales 1.58B 218M 16.85B 2.16B 297M 22.96B
Net income 203M 27.88M 2.16B 307M 42.26M 3.27B
Net Debt - -
More financial data * Estimated data
Logo Inner Mongolia Furui Medical Science Co., Ltd.
Inner Mongolia Furui Medical Science Co., Ltd is a China-based company principally engaged in the diagnosis and treatment of hepatic fibrosis. The Company is mainly engaged in the manufacture and sale of medicines, the research, development and sale of diagnostic equipment, as well as the provision of related services. The Company’s main products include Fufang Biejia Ruangan talbets, Kezhi capsules and instantaneous elastic imaging equipment FibroScan. The Company distributes its products in domestic market and to overseas markets.
Employees
703
Calendar
More about the company
Date Price Change Volume
23/07/24 46.60 ¥ -4.29% 4,322,900
22/07/24 48.69 ¥ +1.23% 2,423,160
19/07/24 48.10 ¥ -2.24% 3,557,028
18/07/24 49.20 ¥ -1.20% 2,909,490
17/07/24 49.80 ¥ +0.71% 2,297,390

End-of-day quote Shenzhen S.E., July 22, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
46.60
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300049 Stock